In today's hyperconnected world, organizations have to work together to defend against cyber attacks. And they need to embed secure technology and procedures more widely.

Partner, Digital and Financial Services, Cyber Platform Lead, Oliver Wyman
Senior Advisor, Oliver Wyman

As the Biden administration leans into the Cancer Moonshot 2.0, the life sciences industry has the opportunity to launch a new era of precision oncology. How can we accelerate progress toward truly personalized medicine and revolutionize cancer care?

President and CEO, COTA, Inc.

CMS released the next evolution of Direct Contracting, boosting the program’s attractiveness and its focus on health equity, as well as scrapping the Geo program.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Actuarial Consulting, Oliver Wyman

Annie Lamont leads one of the nation’s most successful healthcare VC funds. Before she makes an investment, she wants to be sure the leadership team commits to the mission of improving health and healthcare.

Global Leader, Health and Life Sciences, Oliver Wyman
Co-founder and Managing Partner, Oak HC/FT

Healthcare remains a high-profile target for cyberattacks. Following Russia’s invasion of Ukraine, providers across the globe are on high alert.

Principal, Oliver Wyman
Principal, Digital and Health and Life Sciences, Oliver Wyman

Insights in your inbox


Rather than working in silos, software engineers should be embedded alongside the security experts. Start with the security element.

Head of the Digital Investigation Unit at Cranfield University

The growth of digital health has also changed risk exposure for providers and technology companies. Stakeholders need to think broadly about the implications for their businesses and patients.

Director, Transformative Technologies, Marsh McLennan Advantage
Managing Director, US Health Care Practice Leader, Marsh
Communications, Media & Technology, US Practice Leader, Marsh

A Look at What's Inside Oliver Wyman's Health Innovation Journal Vol. 5

Oliver Wyman’s Health Innovation Journal Volume 5 analyzes a number of the biggest trends impacting the industry’s transformation.

Former Virgin Galactic CEO and NASA Chief of Staff George Whitesides knows what it means to take risks and drive change in a complex industry.

Former CEO, Virgin Galactic and Chief of Staff, NASA
Global Leader, Health and Life Sciences, Oliver Wyman

Overheard at the J.P. Morgan Healthcare Conference

Executives detailed plans to take on more risk, build on advances in life sciences, and expressed optimism in Medicare Advantage, despite missing enrollment targets.

Insights in your inbox

Load More